4

Changes in Ownership

Lycia Therapeutics, Inc. Filed 2026-10-27 Acc 0001231919-26-001503

10% owner bought 2,045,440 shares at an average $18.41 ($37,653,863)

10% owner acquired 4,779,793 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
Venrock Healthcare Capital Partners III, L.P. 10% owner	2026-10-23	Purchase	+24,560	$25.68	$630,701	24,560	I
Venrock Healthcare Capital Partners III, L.P. 10% owner	2026-10-23	Purchase	+28,379	$26.11	$740,976	52,939	I
Venrock Healthcare Capital Partners III, L.P. 10% owner	2026-10-26	Conversion	+4,779,793			4,832,732	I
Venrock Healthcare Capital Partners III, L.P. 10% owner	2026-10-26	Purchase	+1,944,444	$18.00	$34,999,992	6,777,176	I
Venrock Healthcare Capital Partners III, L.P. 10% owner	2026-10-26	Purchase	+8,261	$26.97	$222,799	6,785,437	I
Venrock Healthcare Capital Partners III, L.P. 10% owner	2026-10-27	Purchase	+8,729	$25.84	$225,557	6,794,166	I
Venrock Healthcare Capital Partners III, L.P. 10% owner	2026-10-27	Purchase	+31,067	$26.84	$833,838	6,825,233	I
Derivatives
Venrock Healthcare Capital Partners III, L.P. 10% owner	2026-10-26	Conversion · Series C Preferred Stock	−17,142,578			0	I
Venrock Healthcare Capital Partners III, L.P. 10% owner	2026-10-26	Conversion · Series D Preferred Stock	−4,408,091			0	I
Open-market purchases · 2,045,440 sh · avg $18.41 · $37,653,863